<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37990165</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>21</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>A circulating vaccine-derived poliovirus type 2 outbreak in a chronic conflict setting: a descriptive epidemiological study in South Sudan - 2020 to 2021.</ArticleTitle><Pagination><StartPage>816</StartPage><MedlinePgn>816</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">816</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-023-08758-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In this study, we describe the epidemiological profile of an outbreak of the circulating Vaccine Derived Polio Virus type 2 in South Sudan from 2020 to 2021.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">We conducted a retrospective descriptive epidemiological study using data from the national polio/AFP surveillance database, the outbreak investigation reports, and the vaccination coverage survey databases stored at the national level.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Between September 2020 and April 2021, 59 cases of the circulating virus were confirmed in the country, with 50 cases in 2020 and 9 cases in 2021. More cases were males (56%) under five (93%). The median age of the cases was 23.4 ± 11.9 months, ranging from 1 to 84 months. All states, with 28 out of the 80 counties, reported at least one case. Most of the cases (44, 75%) were reported from five states, namely Warrap (31%), Western Bahr el Ghazal (12%), Unity (12%), Central Equatoria (10%), and Jonglei (10%). Four counties accounted for 45.8% of the cases; these are Gogrial West with 12 (20%), Jur River with 5 (8.5%), Tonj North with 5 (8.5%), and Juba with 5 (8.5%) cases. The immunization history of the confirmed cases indicated that 14 (24%) of the affected children had never received any doses of oral polio or injectable vaccines either from routine or during supplemental immunization before the onset of paralysis, 17 (28.8%) had received 1 to 2 doses, while 28 (47.5%) had received 3 or more doses (Fig. 4). Two immunization campaigns and a mop-up were conducted with monovalent Oral Polio Vaccine type 2 in response to the outbreak, with administrative coverage of 91.1%, 99.1%, and 97% for the first, second, and mop-up rounds, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The emergence of the circulating vaccine-derived poliovirus outbreak in South Sudan was due to low population immunity, highlighting the need to improve the country's routine and polio immunization campaign coverage.</AbstractText><CopyrightInformation>© 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tegegne</LastName><ForeName>Ayesheshem Ademe</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Juba, Republic of South Sudan. aysheshema@who.int.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anyuon</LastName><ForeName>Atem Nathan</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Ministry of Health, Juba, Republic of South Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legge</LastName><ForeName>George Awzenio</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Ministry of Health, Juba, Republic of South Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferede</LastName><ForeName>Melisachew Adane</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Juba, Republic of South Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isaac</LastName><ForeName>Zingbondo</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Ministry of Health, Juba, Republic of South Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laku</LastName><ForeName>Kirbak Anthony</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Juba, Republic of South Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biadgilign</LastName><ForeName>Sibhatu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Juba, Republic of South Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kilo</LastName><ForeName>Ochan Taban David</ForeName><Initials>OTD</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Juba, Republic of South Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ndenzako</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Juba, Republic of South Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Modjirom</LastName><ForeName>Ndoutabe</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>World Health Organization Regional Office for Africa, Brazzaville, Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olu</LastName><ForeName>Olushayo Oluseun</ForeName><Initials>OO</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Juba, Republic of South Sudan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>World Health Organization Regional Office for Africa, Brazzaville, Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maleghemi</LastName><ForeName>Sylvester</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Juba, Republic of South Sudan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="Y">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068037" MajorTopicYN="N" Type="Geographic">South Sudan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">And conflict settings</Keyword><Keyword MajorTopicYN="N">Chronic humanitarian</Keyword><Keyword MajorTopicYN="N">Circulating Vaccine Derived Polio Virus type 2</Keyword><Keyword MajorTopicYN="N">Descriptive epidemiology</Keyword><Keyword MajorTopicYN="N">Outbreak response</Keyword><Keyword MajorTopicYN="N">South Sudan</Keyword><Keyword MajorTopicYN="N">cVDPV2 outbreak</Keyword><Keyword MajorTopicYN="N">mOPV2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>22</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37990165</ArticleId><ArticleId IdType="pmc">PMC10664300</ArticleId><ArticleId IdType="doi">10.1186/s12879-023-08758-z</ArticleId><ArticleId IdType="pii">10.1186/s12879-023-08758-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cooper LV, Bandyopadhyay AS, Gumede N, Mach O, Mkanda P, Ndoutabé M, et al. Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa. Lancet Infect Dis. 2022;22(2):284–294. doi: 10.1016/S1473-3099(21)00453-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00453-9</ArticleId><ArticleId IdType="pmc">PMC8799632</ArticleId><ArticleId IdType="pubmed">34648733</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez Gonzalez A, Farrell M, Menning L, Garon J, Everts H, Hampton LM, et al. Implementing the synchronized global switch from trivalent to bivalent oral polio vaccines-lessons learned from the global perspective. J Infect Dis. 2017;216(suppl1):183–S192. doi: 10.1093/infdis/jiw626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw626</ArticleId><ArticleId IdType="pmc">PMC5854099</ArticleId><ArticleId IdType="pubmed">28838179</ArticleId></ArticleIdList></Reference><Reference><Citation>GPEI-OPV. https://polioeradication.org/polio-today/polio-prevention/the-vaccines/opv/. Accessed 22 Jan. 2023.</Citation></Reference><Reference><Citation>Poliomyelitis (polio). https://www.who.int/health-topics/poliomyelitis. Accessed 3 Nov 2022.</Citation></Reference><Reference><Citation>Bigouette JP, Wilkinson AL, Tallis G, Burns CC, Wassilak SGF, Vertefeuille JF. Progress toward polio eradication - worldwide, January 2019-June 2021. MMWR Morb Mortal Wkly Rep. 2021;70(34):1129–1135. doi: 10.15585/mmwr.mm7034a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7034a1</ArticleId><ArticleId IdType="pmc">PMC8389387</ArticleId><ArticleId IdType="pubmed">34437527</ArticleId></ArticleIdList></Reference><Reference><Citation>Chard et al. − 2020 - Progress towards polio eradication – worldwide, Ja.pdf. https://apps.who.int/iris/bitstream/handle/10665/332774/WER9526-283-290-eng-fre.pdf. Accessed 12 Jul 2022.</Citation></Reference><Reference><Citation>boletim-opas-global-update.pdf. https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/p/poliomielite/publicacoes/boletim-opas-global-update. Accessed 26 Jan. 2023.</Citation></Reference><Reference><Citation>Lee SE, Greene SA, Burns CC, Tallis G, Wassilak SGF, Bolu O. Progress toward poliomyelitis eradication — worldwide, January 2021–March 2023. MMWR Morb Mortal Wkly Rep. 2023;72(19):517–522. doi: 10.15585/mmwr.mm7219a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7219a3</ArticleId><ArticleId IdType="pmc">PMC10208367</ArticleId><ArticleId IdType="pubmed">37167156</ArticleId></ArticleIdList></Reference><Reference><Citation>weekly-polio-analyses-WPV. -20221227.pdf. https://polioeradication.org/wp-content/uploads/2022/12/weekly-polio-analyses-WPV-20221227.pdf. Accessed 22 Jan 2023.</Citation></Reference><Reference><Citation>GPEI-OPV Cessation. https://polioeradication.org/polio-today/preparing-for-a-polio-free-world/opv-cessation/. Accessed 22 Jan. 2023.</Citation></Reference><Reference><Citation>Global polio eradication initiative applauds WHO African region for wild polio-free certification. https://www.who.int/news/item/25-08-2020-global-polio-eradication-initiative-applauds-who-african-region-for-wild-polio-free-certification. Accessed 3 Oct 2022.</Citation></Reference><Reference><Citation>Fomban Leke, et al. 2020. Certifying the interruption of wild poliovirus tra.pdf. https://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(20)30382-X.pdf. Accessed 3 Oct 2022.</Citation></Reference><Reference><Citation>Fomban Leke RG, King A, Pallansch MA, Tangermann RH, Mkanda P, Chunsuttiwat S, et al. Certifying the interruption of wild poliovirus transmission in the WHO African region on the turbulent journey to a polio-free world. Lancet Glob Health. 2020;8(10):e1345–1351. doi: 10.1016/S2214-109X(20)30382-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(20)30382-X</ArticleId><ArticleId IdType="pmc">PMC7525084</ArticleId><ArticleId IdType="pubmed">32916086</ArticleId></ArticleIdList></Reference><Reference><Citation>Malawi declares polio outbreak. WHO | Regional Office for Africa. 2023. https://www.afro.who.int/news/malawi-declares-polio-outbreak. Accessed 8 Sept. 2023.</Citation></Reference><Reference><Citation>Alleman et al. Update on Vaccine-Derived Poliovirus Outbreaks-W.pdf. 2021. https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7049a1-H.pdf. Accessed 4 Nov 2022.</Citation></Reference><Reference><Citation>Circulating vaccine-derived poliovirus type 2 – Global update. https://www.who.int/emergencies/disease-outbreak-news/item/circulating-vaccine-derived-poliovirus-type-2-global-update. Accessed 7 Oct 2022.</Citation></Reference><Reference><Citation>Full Text. https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7049a1-H.pdf. Accessed 4 Nov. 2022.</Citation></Reference><Reference><Citation>GPEI-Vaccine-Derived Polioviruses. https://polioeradication.org/polio-today/polio-prevention/the-virus/vaccine-derived-polio-viruses/. Accessed 4 Nov 2022.</Citation></Reference><Reference><Citation>Circulating vaccine-derived. poliovirus type 2 – Global update. https://www.who.int/emergencies/disease-outbreak-news/item/circulating-vaccine-derived-poliovirus-type-2-global-update. Accessed 3 Feb 2023.</Citation></Reference><Reference><Citation>Reporting-and-Classification. -of-VDPVs_Aug2016_EN.pdf. https://polioeradication.org/wp-content/uploads/2016/09/Reporting-and-Classification-of-VDPVs_Aug2016_EN.pdf. Accessed 23 Jan. 2023.</Citation></Reference><Reference><Citation>Voorman A, Lyons H, Bennette C, Kovacs S, Makam JK, Vertefeuille F. Analysis of population immunity to poliovirus following cessation of trivalent oral polio vaccine. Vaccine. 2022;S0264–410X(22):00277–00278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10973941</ArticleId><ArticleId IdType="pubmed">35339308</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper et al. – 2022 - Risk factors for the spread of vaccine-derived typ.pdf. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799632/pdf/main.pdf. Accessed 7 Oct 2022.</Citation></Reference><Reference><Citation>Lv C, As B, N G, O M. Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa. Lancet Infect Dis. 2022;22(2). 10.1016/S1473-3099(21)00453-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8799632</ArticleId><ArticleId IdType="pubmed">34648733</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulating vaccine-derived. poliovirus type 2 – Global update. https://www.who.int/emergencies/disease-outbreak-news/item/circulating-vaccine-derived-poliovirus-type-2-global-update. Accessed 3 Nov 2022.</Citation></Reference><Reference><Citation>Lopalco PL. Wild and vaccine-derived poliovirus circulation, and implications for polio eradication. Epidemiol Infect. 2017;145(3):413–419. doi: 10.1017/S0950268816002569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268816002569</ArticleId><ArticleId IdType="pmc">PMC9507676</ArticleId><ArticleId IdType="pubmed">27866483</ArticleId></ArticleIdList></Reference><Reference><Citation>Implication of a High Risk for Type 2. Vaccine-Derived Poliovirus Emergence and Transmission After the Switch From Trivalent to Bivalent Oral Poliovirus Vaccine | The Journal of Infectious Diseases | Oxford Academic. https://academic.oup.com/jid/article/223/1/113/5867493?login=true. Accessed 12 July 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32621746</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulating vaccine-derived polioviruses: Global update – A new approach to control cVDPV2 [EN/AR/PT] - World | ReliefWeb. https://reliefweb.int/report/world/circulating-vaccine-derived-polioviruses-global-update-new-approach-control-cvdpv2. Accessed 4 Nov 2022.</Citation></Reference><Reference><Citation>poliohl-polio-global. -update-wk11-16mar2022_0.pdf. https://www.paho.org/sites/default/files/poliohl-polio-global-update-wk11-16mar2022_0.pdf. Accessed 26 Jan. 2023.</Citation></Reference><Reference><Citation>Faith MR, Juliet B, Tumuhamye N, Mathias T, Sacks E. Factors associated with the utilization of inactivated polio vaccine among children aged 12 to 23 months in Kalungu District, Uganda. Health Policy Plan. 2020;35(Supplement1):i30–37. doi: 10.1093/heapol/czaa099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/heapol/czaa099</ArticleId><ArticleId IdType="pmc">PMC7649662</ArticleId><ArticleId IdType="pubmed">33165582</ArticleId></ArticleIdList></Reference><Reference><Citation>GPEI-GPEI Strategy. 2022–2026. https://polioeradication.org/gpei-strategy-2022-2026/. Accessed 3 Oct. 2022.</Citation></Reference><Reference><Citation>World Health Organization. – 2022 - Global polio surveillance action plan 2022–2024.pdf. https://polioeradication.org/wp-content/uploads/2022/05/GPSAP-2022-2024-EN.pdf. Accessed 3 Oct 2022.</Citation></Reference><Reference><Citation>Jorba J, Diop OM, Iber J, Henderson E, Zhao K, Quddus A, et al. Update on vaccine-derived poliovirus outbreaks — worldwide, January 2018–June 2019. Morb Mortal Wkly Rep. 2019;68(45):1024. doi: 10.15585/mmwr.mm6845a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6845a4</ArticleId><ArticleId IdType="pmc">PMC6855511</ArticleId><ArticleId IdType="pubmed">31725706</ArticleId></ArticleIdList></Reference><Reference><Citation>South-Sudan. -2018-EPI-Coverage-Survey-2017.pdf. https://www.unicef.org/southsudan/media/1876/file/South-Sudan-2018-EPI-Coverage-Survey-2017.pdf. Accessed 13 Feb 2023.</Citation></Reference><Reference><Citation>Africa eradicates wild poliovirus. WHO | Regional Office for Africa; 2023. https://www.afro.who.int/news/africa-eradicates-wild-poliovirus. Accessed 5 Feb. 2023.</Citation></Reference><Reference><Citation>South-Sudan. -SitRep-December-2020.pdf. https://www.unicef.org/media/91931/file/South-Sudan-SitRep-December-2020.pdf. Accessed 7 Feb. 2023.</Citation></Reference><Reference><Citation>Olu O, Guyo A, Freeman A, Rumunu J, Maleghemi S, Berta K. Assessment of Infection prevention and control readiness for Ebola virus and other diseases outbreaks in a humanitarian crisis setting: a cross-sectional study of health facilities in six high-risk states of South Sudan. Pan Afr Med J. 2022;42:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9475050</ArticleId><ArticleId IdType="pubmed">36158936</ArticleId></ArticleIdList></Reference><Reference><Citation>Amodan et al. – 2022 - Trends of key surveillance performance indicators.pdf. https://bmcpublichealth.biomedcentral.com/counter/pdf/10.1186/s12889-022-14077-w.pdf. Accessed 3 Mar 2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-14077-w.pdf</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunization WEP on. Responding to a suspected polio outbreak: case investigation, surveillance and control, a manager’s checklist. 1991. https://iris.who.int/handle/10665/62380. Accessed 3 Nov 2022.</Citation></Reference><Reference><Citation>WHO_IVB_04.10.pdf. https://apps.who.int/iris/bitstream/handle/10665/68762/WHO_IVB_04.10.pdf?sequence=1&amp;isAllowed=y. Accessed 26 Aug. 2023.</Citation></Reference><Reference><Citation>World Health Organization. Global polio surveillance action plan 2022–2024. 2022. World Health Organization. https://apps.who.int/iris/handle/10665/354479. Accessed 3 Mar 2023.</Citation></Reference><Reference><Citation>Amodan BO, Kisakye A, Okumu PT, Ahirirwe SR, Kadobera D, Driwale A, et al. Trends of key surveillance performance indicators of acute flaccid paralysis: a descriptive analysis, Uganda, 2015–2020. BMC Public Health. 2022;22(1):1694. doi: 10.1186/s12889-022-14077-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-14077-w</ArticleId><ArticleId IdType="pmc">PMC9449289</ArticleId><ArticleId IdType="pubmed">36071410</ArticleId></ArticleIdList></Reference><Reference><Citation>Deteriorating Humanitarian Situation in South Sudan. Rising Attacks on Aid Workers ‘Worrying’ Special Representative Tells Security Council | UN Press. https://press.un.org/en/2021/sc14636.doc.htm. Accessed 9 Oct 2023.</Citation></Reference><Reference><Citation>Climate change. The world’s newest nation is both drying up and drowning | CNN. https://edition.cnn.com/2021/12/06/africa/south-sudan-floods-climate-cmd-intl/index.html. Accessed 26 Aug 2023.</Citation></Reference><Reference><Citation>Climate change and flooding | UNICEF South Sudan. https://www.unicef.org/southsudan/what-we-do/climate-change-and-flooding. Accessed 5 Feb 2023.</Citation></Reference><Reference><Citation>Major problems facing South Sudan today. https://www.africaw.com/major-problems-facing-south-sudan-today. Accessed 27 Aug 2023.</Citation></Reference><Reference><Citation>Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, et al. Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ. 2004;8:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2585883</ArticleId><ArticleId IdType="pubmed">15106296</ArticleId></ArticleIdList></Reference><Reference><Citation>Ming LC, Hussain Z, Yeoh SF, Koh D, Lee KS. Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication. Global Health. 2020;16(1):63. doi: 10.1186/s12992-020-00594-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12992-020-00594-z</ArticleId><ArticleId IdType="pmc">PMC7364572</ArticleId><ArticleId IdType="pubmed">32677974</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetsuriani N, Perehinets I, Nitzan D, Popovic D, Moran T, Allahverdiyeva V, et al. Responding to a cVDPV1 outbreak in Ukraine: implications, challenges and opportunities. Vaccine. 2017;35(36):4769–4776. doi: 10.1016/j.vaccine.2017.04.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.04.036</ArticleId><ArticleId IdType="pmc">PMC10465089</ArticleId><ArticleId IdType="pubmed">28528761</ArticleId></ArticleIdList></Reference><Reference><Citation>Afsar A, Mallya A, Mohammed AAG, Anand S, Diomande VKF, Maufras Du Châtellier G, et al. Monovalent type 2 OPV (mOPV2) management in the field: interventions and lessons learned. Vaccine. 2023;41:A79–A84. doi: 10.1016/j.vaccine.2022.12.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.12.033</ArticleId><ArticleId IdType="pubmed">36642630</ArticleId></ArticleIdList></Reference><Reference><Citation>Maleghemi S, Tegegne AA, Ferede M, Bassey BE, Akpan GU, Bello IM, et al. Polio eradication in a chronic conflict setting lessons from the Republic of South Sudan, 2010–2020. Pan Afr Med J. 2022;42(Suppl 1):3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9474935</ArticleId><ArticleId IdType="pubmed">36158939</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbabazi W, Lako AK, Ngemera D, Laku R, Yehia M, Nshakira N. Maiden immunization coverage survey in the republic of South Sudan: a cross-sectional study providing baselines for future performance measurement. Pan Afr Med J. 2013;16:110. doi: 10.11604/pamj.2013.16.110.3164.</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2013.16.110.3164</ArticleId><ArticleId IdType="pmc">PMC4033584</ArticleId><ArticleId IdType="pubmed">24876899</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustapha T, Kure BC, Hadiza B, Olugbenga OT, Paul BA, Crown RMS, et al. A case study of a circulating vaccine derived polio virus in a Nomad in Zaria – Kaduna state, Nigeria. World J Biology Pharm Health Sci. 2020;3(1):024–028. doi: 10.30574/wjbphs.2020.3.1.0043.</Citation><ArticleIdList><ArticleId IdType="doi">10.30574/wjbphs.2020.3.1.0043</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazira L, Coulibaly T, Mayenga M, Ncharre C, Yogolelo R, Mbule A, et al. [Circulating vaccine-derived poliovirus type 2 outbreak in Democratic Republic of Congo 2011–2012] Bull Soc Pathol Exot. 2015;108(4):235–241. doi: 10.1007/s13149-015-0447-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13149-015-0447-4</ArticleId><ArticleId IdType="pubmed">26288132</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbaeyi C, Alleman MM, Ehrhardt D, Wiesen E, Burns CC, Liu H, et al. Update on vaccine-derived poliovirus outbreaks - Democratic Republic of the Congo and Horn of Africa, 2017–2018. MMWR Morb Mortal Wkly Rep. 2019;68(9):225–230. doi: 10.15585/mmwr.mm6809a2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6809a2</ArticleId><ArticleId IdType="pmc">PMC6421971</ArticleId><ArticleId IdType="pubmed">30845121</ArticleId></ArticleIdList></Reference><Reference><Citation>Strategic response to an outbreak of circulating vaccine-derived poliovirus type 2, Syrian Arab Republic, 2017–2018/Riposte strategique a une flambee de poliovirus circulants derives d’une souche vaccinale de type 2, Republique arabe syrienne, 2017–2018. - Document - Gale Academic OneFile. https://go.gale.com/ps/i.do?id=GALE%7CA630171934&amp;sid=googleScholar&amp;v=2.1&amp;it=r&amp;linkaccess=abs&amp;issn=00498114&amp;p=AONE&amp;sw=w&amp;userGroupName=anon%7E794fcd95. Accessed 12 Jul 2022.</Citation></Reference><Reference><Citation>Wassilak S, Pate MA, Wannemuehler K, Jenks J, Burns C, Chenoweth P, et al. Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population. J Infect Dis. 2011;203(7):898–909. doi: 10.1093/infdis/jiq140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiq140</ArticleId><ArticleId IdType="pmc">PMC3068031</ArticleId><ArticleId IdType="pubmed">21402542</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleem AF, Yousafzai MT, Mach O, Khan A, Quadri F, Weldon WC, et al. Evaluation of vaccine derived poliovirus type 2 outbreak response options: a randomized controlled trial, Karachi, Pakistan. Vaccine. 2018;36(13):1766–1771. doi: 10.1016/j.vaccine.2018.02.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.02.051</ArticleId><ArticleId IdType="pmc">PMC5869272</ArticleId><ArticleId IdType="pubmed">29477307</ArticleId></ArticleIdList></Reference><Reference><Citation>Sufa D, Gerema U. Investigation report of cVDPV2 outbreak in Bokh Woreda of Dollo Zone, Somali Regional State, Ethiopia. Case Rep Infect Dis. 2020;2020:6917313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471813</ArticleId><ArticleId IdType="pubmed">32908734</ArticleId></ArticleIdList></Reference><Reference><Citation>Investigation of Circulating Vaccine Derived. Poliovirus (cVDPV) type 2 outbreak, – Sierra Leone, December 2020 | TEPHINET. https://www.tephinet.org/learning/fead/investigation-of-circulating-vaccine-derived-poliovirus-cvdpv-type-2-outbreak-%E2%80%93-sierra. Accessed 7 Oct 2022.</Citation></Reference><Reference><Citation>Al-Qassimi MA, Al Amad M, Anam L, Almoayed K, Al-Dar A, Ezzadeen F. Circulating vaccine derived polio virus type 1 outbreak, Saadah governorate, Yemen, 2020. BMC Infect Dis. 2022;22(1):414. doi: 10.1186/s12879-022-07397-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07397-0</ArticleId><ArticleId IdType="pmc">PMC9052627</ArticleId><ArticleId IdType="pubmed">35488227</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegegne AA, Maleghemi S, Bakata EMO, Anyuon AN, Legge GA, Kibrak AL, et al. Contribution of auto-visual AFP detection and reporting (AVADAR) on polio surveillance in South Sudan. Pan Afr Med J. 2022;42(Suppl 1):14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9475055</ArticleId><ArticleId IdType="pubmed">36158937</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H. Why have cVDPV2 outbreaks increased globally after the polio immunization strategy switch: challenges for the Polio Eradication Endgame. CCDCW. 2020;2(11):176–179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8393165</ArticleId><ArticleId IdType="pubmed">34594619</ArticleId></ArticleIdList></Reference><Reference><Citation>Auzenbergs M, Fountain H, Macklin G, Lyons H, O’Reilly KM. The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses. Gates Open Res. 2021;5:94. doi: 10.12688/gatesopenres.13272.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/gatesopenres.13272.1</ArticleId><ArticleId IdType="pmc">PMC8913522</ArticleId><ArticleId IdType="pubmed">35299831</ArticleId></ArticleIdList></Reference><Reference><Citation>Snider CJ, Boualam L, Tallis G, Takashima Y, Abeyasinghe R, Lo YR, et al. Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019–2021. Vaccine. 2022. 10.1016/j.vaccine.2022.02.022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10546869</ArticleId><ArticleId IdType="pubmed">35337673</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura K, Shimizu H. Outbreaks of circulating vaccine-derived poliovirus in the World Health Organization Western Pacific Region, 2000–2021. Jpn J Infect Dis. 2022;75(5):431–444. doi: 10.7883/yoken.JJID.2022.312.</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken.JJID.2022.312</ArticleId><ArticleId IdType="pubmed">36047174</ArticleId></ArticleIdList></Reference><Reference><Citation>Standard operating procedures. : responding to a poliovirus event or outbreak. https://www.who.int/publications-detail-redirect/9789240002999. Accessed 7 Oct. 2022.</Citation></Reference><Reference><Citation>Snider CJ, Boualam L, Tallis G, Takashima Y, Abeyasinghe R, Lo Y-R, et al. Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019–2021. Vaccine. 2022;S0264–410X(22):00145–00141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10546869</ArticleId><ArticleId IdType="pubmed">35337673</ArticleId></ArticleIdList></Reference><Reference><Citation>Endegue-Zanga MC, Sadeuh-Mba SA, Iber J, Burns C, Nimpa-Mengouo M, Demanou M, et al. Circulating vaccine-derived polioviruses in the extreme North region of Cameroon. J Clin Virol. 2015;62:80–83. doi: 10.1016/j.jcv.2014.11.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2014.11.027</ArticleId><ArticleId IdType="pubmed">25542478</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>